The Technical Analyst
Select Language :
Aveo Pharmaceuticals Inc [AVEO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Aveo Pharmaceuticals Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Aveo Pharmaceuticals Inc is listed at the  Exchange

0.00% $15.00

America/New_York / 19 jan 2023 @ 16:00


Aveo Pharmaceuticals Inc: Main Fundamentals PE comparison

RATING 2023-02-02
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/213/214/211/222/223/22
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 14.94 - 15.06

( +/- 0.37%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-01-19 Bate Kenneth Sell 375 Common Stock
2023-01-19 Bate Kenneth Sell 22 500 Stock Option (Right to Buy)
2023-01-19 Evnin Anthony B Sell 22 500 Stock Option (Right to Buy)
2023-01-19 Ledell Jebediah Sell 27 702 Stock Option (Right to Buy)
2023-01-19 Ferraresso Michael Sell 220 000 Stock Option (Right to Buy)
INSIDER POWER
46.70
Last 96 transactions
Buy: 43 011 518 | Sell: 9 966 796

Forecast: 01:40 - $17.09

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $15.00 (0.00% )
Volume 0.245 mill
Avg. Vol. 0.564 mill
% of Avg. Vol 43.49 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aveo Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Aveo Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Aveo Pharmaceuticals Inc

Last 10 Buy & Sell Signals For AVEO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Aveo Pharmaceuticals Inc

AVEO

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II clinical trial of tivozanib in combination with Opdivo (nivolumab) for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of squamous cell carcinoma of the head and neck, pancreatic cancer, and acute myeloid leukemia; AV-203, a potent humanized IgG1 monoclonal antibody, which completed Phase I clinical trial for treating human ErbB3; and AV-380, a potent humanized IgG1 inhibitory monoclonal antibody that is in a Phase I clinical trial for the treatment or prevention of cachexia. The company's preclinical stage product includes AV-353 that targets the Notch 3 pathway. AVEO Pharmaceuticals, Inc. has collaboration agreements with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec International GmbH; Kyowa Kirin Co., Ltd.; and AstraZeneca PLC. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
ALICEUSDMar 28 - 10:11$1.907
ONMar 28 - 10:11$74.73
PTENMar 28 - 10:10$11.95
WBAMar 28 - 10:07$20.79
ITCIMar 28 - 10:04$69.13
MSTRMar 28 - 10:02$1 917.00
HUNTUSDMar 28 - 10:020.516
FLIPUSDMar 28 - 09:585.51
DUOLMar 28 - 10:00$218.89
MUMar 28 - 09:57$117.64

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.